mopox,

Jiannan Chen1,2, Liyuan Hu1, Riccardo Vernuccio3

  • 1Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Nature communications
|December 15, 2025
PubMed
概括

研究人员开发了复制缺陷的mpox病毒 (MPXV) 颗粒来研究病毒和选抗病毒药物. 他们确定了G243-1720,一种向病毒蛋白F13的强有力的抑制剂,为病毒感染提供了一种新的治疗方法.